[Walmart Supercentre Exterior thru the Parking Lot] M. Suhail/iStock Editorial via Getty Images Walmart (WMT [https://seekingalpha.com/symbol/WMT]) plans to expand healthcare coverage for its employees next year, offering more than 250 prescription drugs at no cost and introducing additional support for workers and their families, as the retailer continues to develop its employee benefits. The expanded coverage will include generic medicines and branded treatments such as Novo Nordisk’s (NVO [https://seekingalpha.com/symbol/NVO]) Ozempic and Eli Lilly’s (LLY [https://seekingalpha.com/symbol/LLY]) Mounjaro for employees with Type 2 diabetes, subject to prior approval, according to a memo to staff viewed by Bloomberg News.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.